Search Immortality Topics:

Page 67«..1020..66676869..8090..»


Category Archives: Global News Feed

Clene to Host VISIONARY-MS Results Call and Webcast on August 15

SALT LAKE CITY, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) along with its subsidiaries “Clene” and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease, today announced that it will present results from its Phase 2 VISIONARY-MS trial at 7:30 a.m. EDT on Monday, August 15.

Read this article:
Clene to Host VISIONARY-MS Results Call and Webcast on August 15

Posted in Global News Feed | Comments Off on Clene to Host VISIONARY-MS Results Call and Webcast on August 15

Jasper Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

REDWOOD CITY, Calif., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR), a biotechnology company focused on developing multiple new therapies for the field of stem and cellular medicine, today announced second quarter 2022 financial results and provided a corporate update.

View original post here:
Jasper Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

Posted in Global News Feed | Comments Off on Jasper Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

Imago BioSciences Reports Second Quarter 2022 Financial Results and Provides Recent Business Updates

- Positive Data from the Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia (ET) Presented at European Hematology Association (EHA) Meeting 2022 -

See more here:
Imago BioSciences Reports Second Quarter 2022 Financial Results and Provides Recent Business Updates

Posted in Global News Feed | Comments Off on Imago BioSciences Reports Second Quarter 2022 Financial Results and Provides Recent Business Updates

IN8bio Reports Second Quarter 2022 Financial Results and Provides Corporate Update

NEW YORK, Aug. 12, 2022 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on discovering and developing innovative gamma-delta T cell therapies that utilize its DeltEx platform, today announced financial results and operational highlights for the quarter ended June 30, 2022. In addition, the Company provided an overview of recent corporate developments.

Read this article:
IN8bio Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Posted in Global News Feed | Comments Off on IN8bio Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

MIAMI, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers, today announced the granting of inducement awards to five new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the award was made as a material inducement to the five employees’ entry into employment with the Company.

See the rest here:
Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Posted in Global News Feed | Comments Off on Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Adamis Pharmaceuticals Announces Results of Annual Meeting of Stockholders

Meeting adjourned only with respect to reverse stock split proposal until September 8, 2022 Meeting adjourned only with respect to reverse stock split proposal until September 8, 2022

Read the original here:
Adamis Pharmaceuticals Announces Results of Annual Meeting of Stockholders

Posted in Global News Feed | Comments Off on Adamis Pharmaceuticals Announces Results of Annual Meeting of Stockholders